Physician profile
Mark E Neamand
NPI 1194884452
$2,067.18
in general payments reported to CMS, 2019-2025
12 companies · $671 in 2025
The $671 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $94.53 · 2021: $118 · 2022: $119 · 2023: $495 · 2024: $327 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,492.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $694.71 | 2020-2025 | Puraply, Apligraf, Puraply Wound Matrix |
| Mimedx Group, INC. | $342.18 | 2024-2025 | |
| Smith+Nephew, INC. | $222.56 | 2020-2025 | Grafix Pl, Stravix Pl |
| Kci USA, INC. | $199.26 | 2019 | |
| Stryker Corporation | $188.23 | 2024-2025 | Hoffmann, Valor, Easyfuse |
| Kerecis Limited | $179.01 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Osteomed LLC | $96.12 | 2019-2022 | |
| Depuy Synthes Sales INC. | $55.00 | 2023 | Na |
| Angiodynamics, INC. | $54.00 | 2024 | Auryon Laser System 100-120 Vac |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.72 | 2022 | |
| Horizon Therapeutics Plc | $11.88 | 2021 | |
| Orthofix Medical, INC. | $7.51 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Neamand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.